Wednesday, June 3, 2026

Icotrokinra Beneficial for Adults, Teens With Plaque Psoriasis

›
For adults and adolescents with moderate-to-severe  plaque psoriasis , selective blockade of the interleukin-23 receptor with the targeted o...
Tuesday, June 2, 2026

FDA Approves Clotic (clotrimazole otic solution), First Treatment with Clinical Evidence for Fungal Ear Infections

›
In continuation of my update on  clotrimazole Laboratorios Salvat, S.A. ("Salvat") announced today that the U.S. Food and Drug Adm...
Monday, June 1, 2026

Bictegravir and lenacapavir: What is it and is it FDA approved?

›
In continuation of my update on  lenacapavir   lenacapavir   Bictegravir Bictegravir plus lenacapavir (BIC/LEN) is an integrase strand trans...
Saturday, May 30, 2026

Tomato-Soy Juice Shows Promise Against Chronic Inflammation

›
A simple juice made from tomatoes and soybeans may help lower harmful inflammation linked with obesity and chronic disease , according to a...
Friday, May 29, 2026

Could guava juice help prevent anemia?

›
A systematic review from Indonesia, published in the journal BMJ Nutrition, Prevention & Health , indicates that adding guava juice to t...

FDA Approves Rhapsido (remibrutinib) for the Treatment of Chronic Spontaneous Urticaria

›
Novartis announced today that Rhapsido (remibrutinib) received US Food and Drug Administration (FDA) approval as an oral treatment for adult...
Wednesday, May 27, 2026

FDA Approves Foundayo (orforglipron), the Only GLP-1 Pill for Weight Loss That Can be Taken Any Time of Day Without Food or Water Restrictions

›
Eli Lilly and Company (NYSE: LLY)  announced the FDA approval of   Foundayo™ (orforglipron) for adults with obesity, or overweight with weig...
Monday, May 25, 2026

Vitamin C may reduce cancer-linked digestive chemical reactions

›
In continuation of my update on Vitamin C A new study from the University of Waterloo uses mathematical modeling to examine how Vitamin C af...
Thursday, May 21, 2026

FDA Approves Lasix ONYU (furosemide) for Treatment of Edema in Heart Failure

›
SQ Innovation, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its drug-device combination Lasix ONYU (fu...
Wednesday, May 20, 2026

FDA Approves Jascayd (nerandomilast) to Treat Idiopathic Pulmonary Fibrosis

›
Boehringer Ingelheim’s Jascayd (nerandomilast) tablets has been approved by the U.S. Food and Drug Administration (FDA) as an oral treatment...
Tuesday, May 19, 2026

Mavacamten improves obstruction in adolescents with hypertrophic cardiomyopathy

›
In continuation of my update on Mavacamten Adolescent patients with obstructive hypertrophic cardiomyopathy (HCM) who received the drug mava...
Monday, May 18, 2026

Investigational drug delivers mixed results for uncontrolled blood pressure

›
The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, a protein that...
Friday, May 15, 2026

Probing a paradoxical drug response for irregular heartbeat

›
                                                                               Mexiletine https://go.drugbank.com/drugs/DB00379 https://en.w...
Thursday, May 14, 2026

FDA Approves Ferabright (ferumoxytol injection) Contrast Agent for Magnetic Resonance Imaging of the Brain

›
Azurity Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA)  approval of  Ferabright (ferumoxytol injection), the fi...
Monday, May 11, 2026

Small molecule could slow or stop progress of Parkinson's disease and related brain disorders, not just treat symptoms

›
A team of researchers from NYU Abu Dhabi and the University of Denver has identified a promising small molecule that could help slow or halt...